Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0128 Transporter Info | ||||
Gene Name | SLC19A3 | ||||
Transporter Name | Thiamine transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Valproic Acid affects the expression of SLC19A3 mRNA | [35] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene results in increased methylation of SLC19A3 5' UTR | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
1-Methyl-4-phenylpyridinium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC19A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in decreased expression of SLC19A3 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of SLC19A3 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Amprolium |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-Naphthoflavone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-Naphthoflavone results in decreased expression of SLC19A3 mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in decreased methylation of SLC19A3 gene | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
bisphenol A results in increased expression of SLC19A3 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol S |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol S results in increased expression of SLC19A3 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in increased expression of SLC19A3 mRNA | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SLC19A3 gene | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Chloroquine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Deferoxamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Deferoxamine results in decreased expression of SLC19A3 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dorsomorphin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
entinostat |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
entinostat results in increased expression of SLC19A3 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol co-treated with TGFB1 protein results in decreased expression of SLC19A3 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Famotidine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
SLC19A3 protein results in increased uptake of Famotidine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
FR900359 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
FR900359 results in decreased phosphorylation of SLC19A3 protein | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fulvestrant |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A co-treated with Fulvestrant results in decreased methylation of SLC19A3 gene | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Oxygen |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
HIF1A protein affects the reaction Oxygen deficiency results in decreased expression of SLC19A3 protein | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Oxygen deficiency results in decreased expression of SLC19A3 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Oxygen deficiency results in decreased expression of SLC19A3 protein | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
perfluorooctane sulfonic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
perfluorooctane sulfonic acid results in decreased expression of SLC19A3 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
perfluorooctanoic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
perfluorooctanoic acid results in decreased expression of SLC19A3 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Phenformin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
pirinixic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
pirinixic acid binds to and results in increased activity of PPARA protein which results in increased expression of SLC19A3 mRNA | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite affects the methylation of SLC19A3 gene | [33] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased expression of SLC19A3 mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Thiamine |
9 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Metformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation5 |
Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation6 |
SLC19A3 protein results in increased uptake of Thiamine | [34] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation7 |
Thiamine deficiency results in increased expression of SLC19A3 mRNA | [34] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation8 |
Thiamine deficiency results in increased expression of SLC19A3 protein | [34] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation9 |
Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
trichostatin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
trichostatin A results in increased expression of SLC19A3 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Verapamil |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Vitamin K 3 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Vitamin K 3 affects the expression of SLC19A3 mRNA | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Mycotoxins |
|||||
aflatoxin B2 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
aflatoxin B2 results in decreased methylation of SLC19A3 intron | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Phenobarbital |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Phenobarbital affects the expression of SLC19A3 | [1] | |||
Hydrogen Peroxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Hydrogen Peroxide affects the expression of SLC19A3 | [2] | |||
Menadione |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Menadione affects the expression of SLC19A3 | [2] | |||
Zidovudine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zidovudine inhibits the expression of SLC19A3 | [3] | |||
Panobinostat |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Panobinostat increases the expression of SLC19A3 | [4] | |||
Vorinostat |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Vorinostat increases the expression of SLC19A3 | [5] | |||
Cisplatin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cisplatin inhibits the expression of SLC19A3 | [6] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane inhibits the expression of SLC19A3 | [7] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetaminophen inhibits the expression of SLC19A3 | [8] | |||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine inhibits the expression of SLC19A3 | [9] | |||
Valproic Acid |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid increases the expression of SLC19A3 | [10] | |||
Metformin |
8 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Amprolium inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Chloroquine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Famotidine inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Metformin inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation5 |
Metformin inhibits the reaction SLC19A3 protein results in increased uptake of Thiamine | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation6 |
Phenformin inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation7 |
SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation8 |
Verapamil inhibits the reaction SLC19A3 protein results in increased uptake of Metformin | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Drug in Phase 2 Trial |
|||||
Ethanol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Ethanol inhibits the expression of SLC19A3 | [11] | |||
Regulation Mechanism |
via the inhibition of Transcription factor Sp1 (SP1) | Transcription Factor Info | |||
Cell System |
Mouse pancreatic acinar neoplasm cells (266-6) | ||||
MS-275 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
MS-275 increases the expression of SLC19A3 | [5] | |||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A increases the expression of SLC19A3 | [17] | |||
Drug in Phase 1 Trial |
|||||
Quercetin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Quercetin increases the expression of SLC19A3 | [14] | |||
Sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sodium arsenite increases the expression of SLC19A3 | [15] | |||
Trichostatin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Trichostatin A increases the expression of SLC19A3 | [16] | |||
Investigative Drug |
|||||
Beta-naphthoflavone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Beta-naphthoflavone inhibits the expression of SLC19A3 | [19] | |||
Vitamin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
[3H]Thiamine modulates the activity of SLC19A3 | [20] | |||
Acute Toxic Substance |
|||||
Cadmium |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium inhibits the expression of SLC19A3 | [13] | |||
Carcinogen |
|||||
Benzo(a)pyrene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene inhibits the expression of SLC19A3 | [12] | |||
Nickel |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Nickel results in decreased expression of SLC19A3 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Health and Environmental Toxicant |
|||||
Perfluorooctane sulfonic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Perfluorooctane sulfonic acid inhibits the expression of SLC19A3 | [18] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.